Familial hemiplegic migraine: genes and variants
Explore variant evidence for Familial hemiplegic migraine across 3 analyzed proteins (ATP1A2, CACNA1A, SCN1A). Linked ClinVar records include 91 pathogenic or likely pathogenic variants, 397 variants of uncertain significance and 74 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-11-05. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial hemiplegic migraine
ATP1A2: Sodium/potassium-transporting ATPase subunit alpha-2
It restores sodium and potassium gradients after activity in astrocytes and other excitable tissues and thereby supports neuronal ion homeostasis. Pathogenic variants are a major cause of familial hemiplegic migraine type 2 and can produce severe episodic neurologic disease.
45 ClinVar pathogenic / likely pathogenic and 395 uncertain variants in ATP1A2 have source records linked to Familial hemiplegic migraine. Association strength is not clinical gene validity.
CACNA1A: Voltage-dependent P/Q-type calcium channel subunit alpha-1A
Its P/Q-type calcium current is a major trigger for neurotransmitter release at central synapses and is especially important in cerebellar circuits. Pathogenic variants cause a spectrum including familial hemiplegic migraine, episodic ataxia, spinocerebellar ataxia type 6, epilepsy, and developmental disorders.
26 ClinVar pathogenic / likely pathogenic and 39 uncertain variants in CACNA1A have source records linked to Familial hemiplegic migraine. Association strength is not clinical gene validity.
SCN1A: Sodium channel protein type 1 subunit alpha
Its sodium current is especially important for reliable firing of inhibitory interneurons and therefore for balancing excitation across neural networks. Loss-of-function variants are the major cause of Dravet syndrome, while other variants cause GEFS+ or familial hemiplegic migraine.
20 ClinVar pathogenic / likely pathogenic and 36 uncertain variants in SCN1A have source records linked to Familial hemiplegic migraine. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): WDR45.
Where Familial hemiplegic migraine variants cluster
- CACNA1A S4 of repeat III (positions 1339–1357): 4 of 24 ClinVar pathogenic / likely pathogenic variants, 22.0× more than its size predicts (a length-based count, not a validated hotspot).
- CACNA1A S6 of repeat II (positions 689–713): 4 of 24 ClinVar pathogenic / likely pathogenic variants, 16.7× more than its size predicts (a length-based count, not a validated hotspot).
- SCN1A Extracellular (positions 385–397): 3 of 19 ClinVar pathogenic / likely pathogenic variants, 24.4× more than its size predicts (a length-based count, not a validated hotspot).
ClinVar pathogenic and likely pathogenic variants linked to Familial hemiplegic migraine
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| ATP1A2 A606T | 606 | Cytoplasmic | Pathogenic / likely pathogenic (★★★★) |
| ATP1A2 R548H | 548 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G366S | 366 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A R393C | 393 | I | Pathogenic / likely pathogenic (★★) |
| ATP1A2 T263M | 263 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 T376M | 376 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R383H | 383 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G615R | 615 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 V628M | 628 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R834Q | 834 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R937H | 937 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R937C | 937 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CACNA1A V713M | 713 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A R393H | 393 | I | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G301R | 301 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A2 T364M | 364 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 T378N | 378 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R548C | 548 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G855E | 855 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G855R | 855 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CACNA1A R582Q | 582 | II | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1345Q | 1345 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A A1429V | 1429 | III | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R1002Q | 1002 | Transmembrane | Pathogenic / likely pathogenic (★★) |
| CACNA1A A712T | 712 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A L390P | 390 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A L897F | 897 | II | Pathogenic / likely pathogenic (★★) |
| SCN1A Y1781H | 1781 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A A1783T | 1783 | IV | Pathogenic / likely pathogenic (★★) |
| ATP1A2 C341Y | 341 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G715R | 715 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| ATP1A2 G900R | 900 | Extracellular | Pathogenic / likely pathogenic (★★) |
| ATP1A2 P979L | 979 | Extracellular | Pathogenic / likely pathogenic (★★) |
| CACNA1A V1392M | 1392 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A S1798L | 1798 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A V1808I | 1808 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A R1245Q | 1245 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A Y62H | 62 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| CACNA1A R279C | 279 | I | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1348Q | 1348 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A P1352L | 1352 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A T1355N | 1355 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A A1507T | 1507 | III | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1666P | 1666 | IV | Pathogenic / likely pathogenic (★★) |
| CACNA1A R1672P | 1672 | IV | Pathogenic / likely pathogenic (★★) |
| SCN1A Y84C | 84 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A R101W | 101 | Cytoplasmic | Pathogenic / likely pathogenic (★★) |
| SCN1A I227T | 227 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A G271S | 271 | I | Pathogenic / likely pathogenic (★★) |
| SCN1A A1441V | 1441 | III | Pathogenic / likely pathogenic (★★) |
| SCN1A I1545V | 1545 | IV | Pathogenic / likely pathogenic (★★) |
| ATP1A2 R202Q | 202 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 R202W | 202 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 G366V | 366 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 I286T | 286 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 T368M | 368 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 R593L | 593 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 T712M | 712 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
| ATP1A2 G301E | 301 | Transmembrane | Pathogenic / likely pathogenic (★) |
| ATP1A2 G377V | 377 | Cytoplasmic | Pathogenic / likely pathogenic (★) |
Showing 60 of 91.
Uncertain variants prioritized for review in Familial hemiplegic migraine
| Variant | Position | Protein part | Clinical label | Evidence |
|---|---|---|---|---|
| ATP1A2 R593Q | 593 | Cytoplasmic | Conflicting reports (★) | +7: in a 3D region that tolerates change poorly (4R); R593L at the same position is pathogenic; seen in 6.8e-07 of gnomAD DNA copies; REVEL 0.897 |
| ATP1A2 R383C | 383 | Cytoplasmic | Uncertain (★) | +7: in a 3D region that tolerates change poorly (4R); R383H at the same position is pathogenic; seen in 3.4e-06 of gnomAD DNA copies; REVEL 0.900 |
| ATP1A2 T376R | 376 | Cytoplasmic | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; T376M at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| ATP1A2 T378I | 378 | Cytoplasmic | Conflicting reports (★) | +6: 3 other pathogenic changes within 3 positions; T378N at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| ATP1A2 M829T | 829 | Cytoplasmic | Conflicting reports (★) | +6: in a 3D region that tolerates change poorly (4R); M829V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| ATP1A2 T378A | 378 | Cytoplasmic | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; T378N at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| ATP1A2 T811N | 811 | Transmembrane | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; T811R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| ATP1A2 G366D | 366 | Cytoplasmic | Uncertain (★★) | +6: 4 other pathogenic changes within 3 positions; G366V at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
| ATP1A2 R834G | 834 | Cytoplasmic | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; R834L at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| ATP1A2 R383L | 383 | Cytoplasmic | Uncertain (★★) | +6: in a 3D region that tolerates change poorly (4R); R383H at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.95 |
| ATP1A2 T811A | 811 | Transmembrane | Uncertain (★) | +6: 3 other pathogenic changes within 3 positions; T811R at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 0.99 |
| ATP1A2 D808H | 808 | Transmembrane | Uncertain (★) | +6: 2 other pathogenic changes within 3 positions; D808E at the same position is pathogenic; not seen in the gnomAD population database; AlphaMissense 1.00 |
Which prediction tools work for Familial hemiplegic migraine
Observed separation of ClinVar pathogenic / likely pathogenic from benign / likely benign variants (AUROC × 100). This benchmark is not a clinical recommendation.
- CATVariant: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- REVEL: 99 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- AlphaMissense: 97 out of 100
- ESM1b (LLR): 97 out of 100
- EVE: 95 out of 100
- CADD: 95 out of 100
- MutPred: 94 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- MetaSVM: 93 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- PolyPhen-2: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- SIFT: 90 out of 100
- MetaLR: 90 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- phyloP: 77 out of 100
- SpliceAI: 42 out of 100 (learned from overlapping clinical labels, so this is optimistic)
- Pangolin: 41 out of 100 (learned from overlapping clinical labels, so this is optimistic)
Same protein, different disease
- Developmental and epileptic encephalopathy also has ClinVar records linked to ATP1A2 variants; they fall partly in the same places as the Familial hemiplegic migraine variants (8 pathogenic / likely pathogenic).
- Episodic ataxia also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (93 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (85 pathogenic / likely pathogenic).
- Spinocerebellar ataxia also has ClinVar records linked to CACNA1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (28 pathogenic / likely pathogenic).
- Early-infantile DEE also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (422 pathogenic / likely pathogenic).
- Severe myoclonic epilepsy in infancy also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (213 pathogenic / likely pathogenic).
- Generalized epilepsy with febrile seizures plus also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (76 pathogenic / likely pathogenic).
- Developmental and epileptic encephalopathy also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (46 pathogenic / likely pathogenic).
- Autosomal dominant epilepsy also has ClinVar records linked to SCN1A variants; they fall mostly in different places as the Familial hemiplegic migraine variants (4 pathogenic / likely pathogenic).
Diseases related to Familial hemiplegic migraine
- Developmental and epileptic encephalopathy, also linked to ATP1A2, CACNA1A and SCN1A
- Epilepsy, also linked to CACNA1A and SCN1A
- Focal epilepsy, also linked to CACNA1A and SCN1A
- Early-infantile DEE, also linked to SCN1A
- Severe myoclonic epilepsy in infancy, also linked to SCN1A
- Amyotrophic lateral sclerosis, also linked to SCN1A
- Episodic ataxia, also linked to CACNA1A
- Generalized epilepsy with febrile seizures plus, also linked to SCN1A
- Cardiac arrhythmia, also linked to SCN1A
- Spinocerebellar ataxia, also linked to CACNA1A
- Familial febrile seizures, also linked to SCN1A
- Alternating hemiplegia of childhood, also linked to ATP1A2
Frequently asked questions
Which genes have records linked to Familial hemiplegic migraine?
This view contains 3 analyzed proteins: ATP1A2, CACNA1A, SCN1A. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 91 pathogenic or likely pathogenic variants, 397 variants of uncertain significance and 74 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 12 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 605 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center